| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.38 | 2e-15 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-09 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.27 | 8e-09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.39 | 2e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-08 |